在患有刺激性肠综合征的儿科患者中针对腹壁的肌性释放疗法:可行性和可接受性研究
Anish Rana1, Jordan Dourlain1, Robin Miccio1
1Children's Hospital of Philadelphia, Department of Gastroenterology, Hepatology, and Nutrition, Integrative Health Program, Philadelphia, USA.
International journal of therapeutic massage & bodywork
|December 13, 2024
概括
肌肌释放疗法 (MFR) 是对患有刺激性肠综合征 (IBS) 的儿童的可行和受欢迎的治疗方法. 这项研究发现,MFR在改善儿科IBS患者的症状和生活质量方面是安全有效的.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 补充和替代医学 补充和替代医学
- 疼痛管理 疼痛管理
背景情况:
- 刺激性肠综合征 (IBS) 是一种功能性胃肠疾病,其特点是腹痛,胀气和改变肠道习惯,显著影响生活质量 (QoL).
- 目前的IBS治疗方法对许多患者提供了有限的缓解,突出显示了对新型治疗方法的需求.
- 肌肌释放 (MFR) 是一种手动治疗技术,针对带限制,在成年IBS患者中已证明有好处,但其在儿童中的使用仍未评估.
研究的目的:
- 评估在被诊断为IBS的儿童中腹壁向肌肌释放 (MFR) 的可行性和可接受性.
- 评估MFR作为儿科IBS的潜在治疗选择.
主要方法:
- 一项前性研究涉及10名儿童 (年龄在13-18岁),符合IBS的罗马IV标准.
- 参与者每周接受6次1小时的MFR课程,由执照的按摩治疗师进行,并补充在家进行自我MFR练习.
- 通过REDCap数据收集来衡量可行性和可接受性,同时使用经过验证的儿科问卷评估干预前后的症状严重程度和QoL.
主要成果:
- 所有10名参与者都完成了为期6周的MFR协议,显示出高度坚持 (90%的中位数符合访问).
- 经过许可的按摩治疗师成功地在所有参与者中识别并释放了带限制.
- 该干预措施被很好地容忍,参与者报告的疼痛程度很小,没有不良事件. 大多数参与者自愿提供了积极的反.
结论:
- 针对腹壁的MFR对于患有IBS的儿科患者来说是一个可行的和高度可接受的干预措施.
- 这些发现支持MFR作为一种安全和潜在的有益疗法,用于改善IBS儿童的症状和QoL.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
140
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
140
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
Irritable Bowel Syndrome III: Medical and Nursing Management
167
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
167
Drugs for Treatment of Constipation-Predominant IBS
134
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
134
Irritable Bowel Syndrome I: Introduction
246
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
246
Inflammatory Bowel Disease V: Surgical Management
118
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
118


